4.46
前日終値:
$4.63
開ける:
$4.61
24時間の取引高:
533.74K
Relative Volume:
0.63
時価総額:
$501.75M
収益:
$69.56M
当期純損益:
$-240.05M
株価収益率:
-1.5119
EPS:
-2.95
ネットキャッシュフロー:
$-121.90M
1週間 パフォーマンス:
+9.05%
1か月 パフォーマンス:
+11.50%
6か月 パフォーマンス:
+211.89%
1年 パフォーマンス:
+58.16%
Adc Therapeutics Sa Stock (ADCT) Company Profile
ADCT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ADCT
Adc Therapeutics Sa
|
4.46 | 520.87M | 69.56M | -240.05M | -121.90M | -2.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-08 | 開始されました | Stephens | Overweight |
| 2024-05-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-03-28 | 開始されました | Guggenheim | Buy |
| 2023-08-10 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-04-24 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-12-06 | 開始されました | CapitalOne | Overweight |
| 2022-11-09 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-09-21 | 開始されました | JP Morgan | Overweight |
| 2022-09-09 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-09 | 開始されました | Wolfe Research | Outperform |
| 2021-08-17 | 再開されました | Jefferies | Buy |
| 2021-08-09 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-06-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-12-03 | 開始されました | Stifel | Hold |
| 2020-10-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-06-09 | 開始されました | BofA/Merrill | Buy |
| 2020-06-09 | 開始されました | Cowen | Outperform |
すべてを表示
Adc Therapeutics Sa (ADCT) 最新ニュース
ADC Therapeutics (NYSE:ADCT) Reaches New 1-Year HighTime to Buy? - MarketBeat
What earnings revisions data tells us about ADC Therapeutics SAJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
Is ADC Therapeutics SA stock dividend yield sustainableQuarterly Market Summary & Reliable Breakout Forecasts - newser.com
Is ADC Therapeutics SA stock a top pick in earnings seasonQuarterly Earnings Summary & Fast Gain Stock Trading Tips - newser.com
ADC Therapeutics SA (NYSE:ADCT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
How to track smart money flows in ADC Therapeutics SA2025 Investor Takeaways & Target Return Focused Picks - newser.com
ADC Therapeutics (ADCT) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Momentum divergence signals in ADC Therapeutics SA chartMarket Growth Report & Low Drawdown Momentum Trade Ideas - newser.com
Will ADC Therapeutics SA Common Shares stock beat Nasdaq index returnsTrade Volume Summary & Weekly Top Gainers Alerts - newser.com
Will ADC Therapeutics SA Common Shares stock boost dividends furtherWeekly Risk Report & Entry and Exit Point Strategies - newser.com
Is ADC Therapeutics SA stock bottoming outJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
Using AI based signals to follow ADC Therapeutics SATrade Risk Report & Community Verified Swing Trade Signals - newser.com
Is ADC Therapeutics SA showing signs of accumulationPortfolio Risk Report & Weekly Consistent Profit Watchlists - newser.com
Is it time to cut losses on ADC Therapeutics SAWeekly Trend Recap & Fast Entry Momentum Alerts - newser.com
Is ADC Therapeutics SA stock cheap compared to fundamentalsWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com
Visual analytics tools that track ADC Therapeutics SA performance2025 Short Interest & Community Trade Idea Sharing - newser.com
What insider trading reveals about ADC Therapeutics SA stockPortfolio Update Report & Stepwise Entry/Exit Trade Alerts - newser.com
Is ADC Therapeutics SA stock a buy on dips2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
ADC Therapeutics SA stock outlook for YEARJuly 2025 Setups & Expert Verified Stock Movement Alerts - newser.com
Why retail traders accumulate ADC Therapeutics SA Common Shares stockBuy Signal & Low Drawdown Trading Strategies - newser.com
Why analysts upgrade ADC Therapeutics SA stock2025 Major Catalysts & Reliable Entry Point Trade Alerts - newser.com
Will ADC Therapeutics SA Common Shares stock draw ESG focused funds2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
What indicators show strength in ADC Therapeutics SAWeekly Trade Review & Verified Chart Pattern Trade Signals - newser.com
Is ADC Therapeutics SA Common Shares stock trading at attractive multiplesPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
Is ADC Therapeutics SA stock attractive for long term wealth buildingBull Run & Consistent Return Strategy Ideas - newser.com
Fed Watch: Why analysts upgrade ADC Therapeutics SA stockJuly 2025 Reactions & Weekly Top Stock Performers List - Fundação Cultural do Pará
How analysts rate ADC Therapeutics SA stock todayWeekly Risk Report & Free Community Supported Trade Ideas - Fundação Cultural do Pará
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025 - Quantisnow
ADC Therapeutics SA stock chart pattern explainedPortfolio Risk Report & Safe Entry Trade Signal Reports - newser.com
How institutional ownership impacts ADC Therapeutics SA stockEarnings Overview Report & Safe Entry Momentum Stock Tips - newser.com
Whale Trades: Why analysts upgrade ADC Therapeutics SA stockDividend Hike & High Accuracy Trade Alerts - Fundação Cultural do Pará
Adc Therapeutics Sa (ADCT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):